User: Guest  Login
Title:

Combined proteomics and CRISPR Cas9 screens in PDX identify ADAM10 as essential for leukemia in vivo

Document type:
Zeitschriftenaufsatz
Author(s):
Bahrami, Ehsan ; Schmid, Jan Philipp ; Jurinovic, Vindi ; Becker, Martin ; Wirth, Anna-Katharina ; Ludwig, Romina ; Kreissig, Sophie ; Duque Angel, Tania Vanessa ; Amend, Diana ; Hunt, Katharina ; Öllinger, Rupert ; Rad, Roland ; Frenz, Joris Maximilian ; Solovey, Maria ; Ziemann, Frank ; Mann, Matthias ; Vick, Binje ; Wichmann, Christian ; Herold, Tobias ; Jayavelu, Ashok Kumar ; Jeremias, Irmela
Keywords:
Research ; Genome Editing and the Future of Personalized and Targeted Cancer Medicine ; CRISPR-Cas9 in vivo screen ; Proteomics ; ADAM10 ; PDX ; Acute leukemia ; Leukemia stem cells ; Medical and Health Sciences
Journal title:
Molecular Cancer
Year:
2023
Journal volume:
22
Journal issue:
1
Fulltext / DOI:
doi:10.1186/s12943-023-01803-0
Publisher:
BioMed Central
E-ISSN:
1476-4598
Date of publication:
08.07.2023
 BibTeX